Podcasts

You can sponsor a Drug Discovery Today podcast and engage with new prospects via a powerful online broadcast hosted live on our website.

Podcasts provide an audio platform to make a major announcement. Why not take the opportunity to use this facility to launch a new product and combine your broadcast with a video demo or other visual information. Our easy-to-use, yet detailed, online registration process provides you with a list of pre-qualified leads.

To find out more about how you can be involved with podcasts hosted by Drug Discovery Today contact us today.

Listen Now

Evotec strengthens and expands its Alliance Business

Dr Mark Ashton is Executive Vice President, Business Development of Evotec and is responsible for Evotec's commercial and partnering activities. Prior to assuming responsibility for Business Development in 2005, Dr Ashton held a number of positions within Operations at Evotec: He joined the Company in 1995 as one of the initial employees of the Discovery Division, becoming Department Manager in 2001, Director of Chemistry Services in 2002 and taking over responsibility for Evotec's Discovery Services Division in 2004, where he had responsibility for Evotec's screening, parallel synthesis and medicinal chemistry operations. During his time at Evotec, Dr Ashton has managed a wide range of pharmaceutical and biotechnology related projects, including medicinal chemistry projects, design and synthesis of screening libraries and technology transfer projects and has been involved in the progression of a number of drug candidates into the clinic in numerous therapeutic areas.

Dr Ashton has authored and co-authored a number of peer reviewed papers, articles and book chapters in addition to being named on a number of pharmaceutical patents. He is trained as a medicinal chemist. Prior to joining Evotec, Dr Ashton also had spells at ICI Pharmaceuticals and Organon Laboratories.

Mark Whittaker is Senior Vice President Drug Discovery at Evotec where he manages a large drug discovery collaboration and the groups of computational chemistry and structural biology. Before joining Evotec in 2001, Mark spent 13 years at British Biotech Pharmaceuticals where he led a number of medicinal chemistry programmes and was latterly Director of Chemistry. At British Biotech, Mark contributed to the discovery and development of six compounds that have progressed into human clinical trials. Before his career at British Biotech, Mark carried out post-doctoral research at the University of Oxford and at York University, Toronto and obtained a D. Phil in Chemistry from the University of York.
03 December 2009

The Ubiquitin Story

In this podcast interview with Drug Discovery Today, Nobel Prize winner Professor Aaron Ciechanover will talk about his career, his Nobel Prize-winning discovery of the UPS, and the extraordinary opportunities and challenges for drug discovery in this area.
01 July 2009

Califf, Behrman and Kramer discuss the Clinical Trials Transformation Initiative.

Download the Califf, Behrman and Kramer podcast as an mp3 file
01 March 2009

Dr Brent Vose outlines AstraZeneca's oncology pipeline.

Download the Dr. Brent Vose podcast as an mp3 file
01 November 2008

David Bylund talks about the development of antidepressant medicines.

Download the Prof. David Bylund podcast as an mp3 file
01 August 2008

Dr. Cosper discusses biological medicines with Steve Carney.

Download the Dr. Nate Cosper podcast as an mp3 file
01 July 2008

Chris Lipinski shares his opinions on the current scientific position of the Pharmaceutical Industry.

Download the Dr. Christopher Lipinski podcast as an mp3 file
01 March 2008

Stephen Minger outlines the role of stem cells in the Pharmaceutical Industry.

Download the Dr. Stephen Minger podcast as an mp3 file
01 November 2007